EDELRIS

EDELRIS is a pioneering company dedicated to the design and chemical synthesis of innovative natural product-like screening Libraries, medicinal chemistry Hit-to-Lead / Lead Optimization projects, Custom Synthesis, and Affinity screening-Mass Spectrometry (AS-MS). Aiming at the acceleration of the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS uses its recognized chemistry and screening expertise in drug discovery to provide novelty to its clients and partners. Our unique and first-in-class NP-like, easily tractable screening libraries (Fragments, Covalent binders, conventional HTS & DEL) now contain +2M in-house synthesized compounds, with built-in hit-to-lead optimization capabilities. These libraries can be reviewed...

Natural product like compound collections,fragment libraries,dna encoded libraries,compound screening,affinity screening - mass spectrometry,virtual screening,synthetic chemistry,organic chemistry,medicinal chemistry,analytical chemistry,and covalent inhibitors

Edelris operates in the Biotechnology research industry.

Edelris's revenue is 11m - 100m

Edelris has 51 - 200 employees.